Development of a liquid chromatography/tandem mass spectrometry assay for the quantification of PM02734, a novel antineoplastic agent, in dog plasma

Rapid Communications in Mass Spectrometry

Volumn 20, Issue 18, 2006, Pages 2735-2740

  Yin, Jianming ^a   Aviles, Pablo ^b   Lee, William ^a   Ly, Carl ^a   Guillen, Maria Jose ^b   Munt, Simon ^b   Cuevas, Carmen ^b   Faircloth, Glynn ^a  

^a PharmaMar USA Inc   (United States)

^b PHARMAMAR S A   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; QUALITY CONTROL;

ACCURACY AND PRECISION; ANTINEOPLASTIC AGENTS; CALIBRATION STANDARD; DOG PLASMA; INTERNAL STANDARDS; LIMIT OF QUANTIFICATIONS; LIQUID CHROMATOGRAPHY-TANDEM MASS SPECTROMETRY ASSAYS; LIQUID CHROMATOGRAPHY/TANDEM MASS SPECTROMETRY; PM02734; SENSITIVE LIQUID CHROMATOGRAPHY-TANDEM MASS SPECTROMETRY;

CALIBRATION;

EID: 33749343371     PISSN: 09514198     EISSN: 10970231     Source Type: Journal    
DOI: 10.1002/rcm.2644     Document Type: Article

References (4)

1. Hamann MT, Otto CS, Scheuer PJ. J. Org. Chem. 1996; 61: 6594.
2. Jimeno J, Faircloth G, Fernandez Sousa-Faro JM, Scheuer P, Rinehart K. Marine Drugs 2004; 2: 14.
3. Gabrielsson J, Weiner D. Pharmacokinetic/Pharmacodynamic Data Analysis: Concept and Applications. (3rd edn). Swedish Pharmaceutical Press: Stockholm, 2000; chap. 1-3.
4. Mallet CR, Lu Z, Mazzeo JR. Rapid Commun. Mass Spectrom. 2004; 18: 49.